BAP1, BRCA1, BRCA2, CDK4, CDKN2A, CHEK2, MC1R, MITF, POT1, PTCH1, PTEN, RB1, TP53
Hayward NK, et al. Genetics of melanoma predisposition. Oncogene. 2003 May 19;22(20):3053-62.
Puntervoll HE, et al. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J Med Genet. 2013 Apr;50(4):264-70.
Begg CB, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15.
Kefford RF, et al. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol. 1999;17(10):3245-51.